Evidence map›Paper›PMID 19091743›Full record

ReviewThe Journal of biological chemistry2009

Signaling threshold regulation by the Ras effector IMP.

Sharon A Matheny, Michael A White

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Mutation ofCancers · 2022
    Article
  3. Article
  4. Article
  5. TheG3 (Bethesda, Md.) · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Mitogen-Activated Protein (MAP) Kinase Scaffolding Proteins: A Recount.International journal of molecular sciences · 2013
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sharon A MathenyZimmer Biologics, Austin, Texas 78729, USA.
Michael A White
The University of Texas Southwestern Medical Center · US

Funding

COMPONENTS OF RAS-MEDIATED GROWTH CONTROLR01CA071443 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WHITE, MICHAEL A. · 1996 to 2015
$4.8M
NCI NIH HHS CA71443
6 · The paper itself

Abstract

The Ras effector and E3 ligase family member IMP (impedes mitogenic signal propagation) acts as a steady-state resistor within the Raf-MEK-ERK kinase module. IMP concentrations are directly regulated by Ras, through induction of autoubiquitination, to permit productive Raf-MEK complex assembly. Inhibition of Raf-MEK pathway activation by IMP occurs through the inactivation of KSR, a scaffold/adapter protein that couples activated Raf to its substrate MEK1. The capacity of IMP to inhibit signal propagation through Raf to MEK is, in part, a consequence of disrupting KSR1 homo-oligomerization and c-Raf-B-Raf hetero-oligomerization. These observations suggest that IMP functions as a threshold modulator, controlling sensitivity of the cascade to stimulus by directly limiting the assembly of functional KSR1-dependent Raf-MEK complexes.

Indexed as

Signal TransductionAnimalsDimerizationHumansMAP Kinase Kinase 1Models, BiologicalProtein BindingProtein Structure, TertiaryProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-rafras ProteinsSubstrate SpecificityUbiquitin-Protein LigasesBRAP protein, humanMAP Kinase Kinase 1Proto-Oncogene Proteins B-rafProto-Oncogene Proteins c-rafras ProteinsUbiquitin-Protein Ligases

Identifiers

PMID19091743
PMCPMC2670105
OpenAlexW2008315340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.